
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $9.9M | -- | -- | -$1.91 | -- |
07/31/2025 | Q2 | $9.5M | -- | -- | -$1.78 | -- |
05/01/2025 | Q1 | $9.7M | $8.7M | -$1.55 | -$1.76 | $0.21 |
02/13/2025 | Q4 | $9.3M | $10.7M | -$1.74 | -$1.63 | -$0.11 |
10/31/2024 | Q3 | $9.5M | $9M | $16.22 | $7.91 | $8.31 |
08/01/2024 | Q2 | $9.3M | $8.6M | -$1.69 | -$1.61 | -$0.08 |
05/02/2024 | Q1 | $8.4M | $8.2M | -$1.45 | -$1.69 | $0.24 |
02/15/2024 | Q4 | $7.9M | $7.1M | -$1.72 | -$1.64 | -$0.08 |
11/02/2023 | Q3 | -- | -- | -$1.64 | -$1.64 | -$0.00 |
08/03/2023 | Q2 | -- | -- | -$1.51 | -$1.50 | -$0.01 |
05/04/2023 | Q1 | -- | -- | -$1.47 | -$1.72 | $0.25 |
02/23/2023 | Q4 | -- | -- | $0.67 | -$1.54 | $2.21 |
11/03/2022 | Q3 | -- | -- | -$1.49 | -$1.71 | $0.22 |
08/04/2022 | Q2 | -- | -- | -$1.68 | -$1.78 | $0.10 |
05/05/2022 | Q1 | -- | -- | -$1.74 | -$1.76 | $0.02 |
02/24/2022 | Q4 | -- | -- | -$1.74 | -$1.57 | -$0.17 |
11/03/2021 | Q3 | -- | -- | -$1.56 | -$1.57 | $0.01 |
07/29/2021 | Q2 | -- | -- | -$1.41 | -$1.28 | -$0.13 |
04/29/2021 | Q1 | -- | -- | $26.95 | -$1.26 | $28.21 |
02/25/2021 | Q4 | -- | -- | -$1.41 | -$1.31 | -$0.10 |
11/05/2020 | Q3 | -- | -- | -$1.43 | -$1.36 | -$0.07 |
07/30/2020 | Q2 | -- | -- | -$1.31 | -$1.36 | $0.05 |
04/30/2020 | Q1 | -- | -- | -$0.59 | -$1.64 | $1.05 |
02/13/2020 | Q4 | -- | -- | -$1.60 | -$1.68 | $0.08 |
10/31/2019 | Q3 | -- | -- | -$1.81 | -$1.81 | -$0.00 |
08/01/2019 | Q2 | -- | -- | -$1.87 | -$1.70 | -$0.17 |
05/02/2019 | Q1 | -- | -- | -$1.59 | -$1.75 | $0.16 |
02/14/2019 | Q4 | -- | -- | -$1.58 | -$1.66 | $0.08 |
11/01/2018 | Q3 | -- | -- | -$1.63 | -$1.62 | -$0.01 |
08/02/2018 | Q2 | -- | -- | -$1.19 | -$1.55 | $0.36 |
05/04/2018 | Q1 | -- | -- | -$1.63 | -$1.65 | $0.02 |
02/14/2018 | Q4 | -- | -- | -$1.81 | -$1.61 | -$0.20 |
11/01/2017 | Q3 | -- | -- | -$1.59 | -$1.78 | $0.19 |
08/08/2017 | Q2 | -- | -- | -$1.78 | -$1.57 | -$0.21 |
05/04/2017 | Q1 | -- | -- | -$1.56 | -$1.80 | $0.24 |
02/16/2017 | Q4 | -- | -- | -$1.34 | -$1.51 | $0.17 |
11/03/2016 | Q3 | -- | -- | -- | -- | -- |
08/04/2016 | Q2 | -- | -- | -- | -- | -- |
05/05/2016 | Q1 | -- | -- | -- | -- | -- |
02/18/2016 | Q4 | -- | -- | -- | -- | -- |
11/05/2015 | Q3 | -- | -- | -- | -- | -- |
Agios Pharmaceuticals reported $8.7M worth of top line sales in its most recent quarter.
Agios Pharmaceuticals announced earnings per share of -$1.55 which represents a beat of analyst forecast a -$1.76 per share.
Agios Pharmaceuticals reported $7.6M that represents $0.13 per share over the last quarter.
Agios Pharmaceuticals's earnings are forecast to decrease from $11.64 per share to $11.21 per share next year representing a decrease of -69.54%.
Agios Pharmaceuticals's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.